Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000878472 | SCV001021385 | benign | Tatton-Brown-Rahman overgrowth syndrome | 2025-01-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001585853 | SCV001813285 | likely benign | not provided | 2021-01-28 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002495331 | SCV002796051 | benign | Acute myeloid leukemia; Tatton-Brown-Rahman overgrowth syndrome; Heyn-Sproul-Jackson syndrome | 2021-10-21 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003920472 | SCV004731002 | benign | DNMT3A-related disorder | 2022-08-17 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |